Insulin inhibits amyloid β-induced cell death in cultured human brain pericytes

Neurobiology of Aging

Volumn 25, Issue 1, 2004, Pages 93-103

  Rensink, Annemieke A M ^a   Otte Höller, Irene ^a   De Boer, Roelie ^a   Bosch, Remko R ^a   Ten Donkelaar, Hans J ^a   De Waal, Robert M W ^a   Verbeek, Marcel M ^a,b   Kremer, Berry ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Neurology ^*  (Netherlands)

Author keywords

Alzheimer's disease; Amyloid ; Fibril formation; Human brain pericytes; Insulin

Indexed keywords

AMYLOID BETA PROTEIN; INSULIN; PROTEIN INHIBITOR;

ARTICLE; CELL ASSAY; CELL CULTURE; CELL DEATH; CELL DEGENERATION; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; FIBER; HUMAN; HUMAN CELL; MODEL; NERVE CELL; PERICYTE; PRIORITY JOURNAL;

EID: 0346220380     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00039-3     Document Type: Article

References (39)

1. Barber A.J., Nakamura M., Wolpert E.B., Reiter C.E., Seigel G.M., Antonetti D.A.et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J. Biol. Chem. 276(35):2001;32814-32821.
2. Bernstein H.G., Ansorge S., Riederer P., Reiser M., Frolich L., Bogerts B. Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci. Lett. 263(2/3):1999;161- 164.
3. Brange J., Andersen L., Laursen E.D., Meyn G., Rasmussen E. Toward understanding insulin fibrillation. J. Pharm. Sci. 86(5):1997;517-525.
4. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P.et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 360(6405):1992;672-674.
5. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Jr.et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 50(1):1998;164-168.
6. Davis-Salinas J., Van Nostrand W.E. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J. Biol. Chem. 270(36):1995;20887-20890.
7. Davis J., Van Nostrand W.E. Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc. Natl. Acad. Sci. U.S.A. 93(7):1996;2996-3000.
8. Dore S., Kar S., Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U.S.A. 94(9):1997;4772-4777.
9. Frolich L., Blum-Degen D., Bernstein H.G., Engelsberger S., Humrich J., Laufer S.et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. 105(4/5):1998;423-438.
10. Frolich L., Blum-Degen D., Riederer P., Hoyer S. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann. N.Y. Acad. Sci. 893:1999;290-293.
11. Gasparini L., Netzer W.J., Greengard P., Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23(6):2002;288-293.
12. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120(3):1984;885-890.
13. Hoyer S. Models of Alzheimer's disease: cellular and molecular aspects. J. Neural Transm. Suppl. 49:1997;11-21.
14. Kurochkin I.V. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Lett. 427(2):1998;153-156.
15. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2(3):1993;404-410.
16. LeVine H. III Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:1999;274-284.
17. Mandarino L.J., Finlayson J., Hassell J.R. High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. Invest. Ophthalmol. Vis. Sci. 35(3):1994;964-972.
18. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17(3):1997;1046-1054.
19. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12(2):1992;376-389.
20. Melchor J.P., Van Nostrand W.E. Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells. J. Biol. Chem. 275(13):2000;9782-9791.
21. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M.et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
22. Naslund J., Haroutunian V., Mohs R., Davis K.L., Davies P., Greengard P.et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283(12):2000;1571-1577.
23. Nettleton E.J., Tito P., Sunde M., Bouchard M., Dobson C.M., Robinson C.V. Characterization of the oligomeric states of insulin in self-assembly and amyloid fibril formation by mass spectrometry. Biophys. J. 79(2):2000;1053-1065.
24. Parpura-Gill A., Beitz D., Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 754(1/2):1997;65-71.
25. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13(4):1993;1676-1687.
26. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B.et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273(49):1998;32730-32738.
27. Rensink A.A.M., Verbeek M.M., Otte-Holler I., Ten Donkelaar H.J., De Waal R.M.W., Kremer B. Inhibition of amyloid β-induced cell death in human brain pericytes in vitro. Brain Res. 952:2002;111-121.
28. Takadera T., Sakura N., Mohri T., Hashimoto T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161(1):1993;41-44.
29. Van Duinen S.G., Castano E.M., Prelli F., Bots G.T., Luyendijk W., Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 84(16):1987;5991-5994.
30. Van Nostrand W.E., Melchor J.P., Ruffini L. Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70(1):1998;216-223.
31. Vekrellis K., Ye Z., Qiu W.Q., Walsh D., Hartley D., Chesneau V.et al. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J. Neurosci. 20(5):2000;1657-1665.
32. Verbeek M.M., De Waal R.M., Schipper J.J., Van Nostrand W.E. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J. Neurochem. 68(3):1997;1135-1141.
33. Verbeek M.M., Eikelenboom P., De Waal R.M. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56(7):1997;751-761.
34. Verbeek M.M., Otte Holler I., Wesseling P., Ruiter D.J., De Waal R.M. Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am. J. Pathol. 144(2):1994;372-382.
35. Verbeek MM, Van Nostrand WE, De Waal RMW. Degeneration of human cerebrovascular smooth muscle cells and pericytes caused by amyloid β protein. In: Verbeek MM, De Waal RMW, Vinters HV, editors. Cerebral amyloid angiopathy in Alzheimer's disease and related disorders. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2000. p. 265-79.
36. Verbeek M.M., Westphal J.R., Ruiter D.J., De Waal R.M. T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J. Immunol. 154(11):1995;5876-5884.
37. Wisniewski H.M., Wegiel J., Wang K.C., Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol. 84:1992;117-127.
38. Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22(10):2002;RC221.
39. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science. 250(4978):1990;279-282.